Cabio Biotech (Wuhan) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	226.85	278.23	153.15	239.68	494.33	664.47
Trading Asset Securities	160	-	0.03	0.03	32.8	11.5
Cash & Short-Term Investments	386.85	278.23	153.18	239.71	527.13	675.97
Cash Growth	86.01%	81.63%	-36.10%	-54.53%	-22.02%	-21.48%
Accounts Receivable	135.98	196.56	285.41	265.64	216.43	178.29
Other Receivables	25.73	24.02	36.39	31.01	40.56	41.08
Receivables	161.7	220.58	321.81	296.65	256.99	219.37
Inventory	205.73	173.27	139.32	112.58	81.49	74.86
Other Current Assets	48.11	49.63	42.36	59.84	41.76	24.66
Total Current Assets	802.39	721.72	656.67	708.78	907.37	994.85
Property, Plant & Equipment	892.28	891.77	767.92	643.28	485.96	241.93
Long-Term Investments	154.09	176.51	191.84	175.37	150.22	117.31
Other Intangible Assets	42.83	43.47	43.09	41.08	36.34	13.15
Long-Term Deferred Tax Assets	11.8	11.8	9.36	11.13	11.49	5.98
Long-Term Deferred Charges	0.2	0.42	1.86	3.67	2.45	0.38
Other Long-Term Assets	16.81	13.98	16.07	28.18	17.52	74.89
Total Assets	1,920	1,860	1,687	1,611	1,611	1,448
Accounts Payable	90.51	93.25	62.07	70.86	107.34	31.43
Accrued Expenses	5.96	11.47	21.97	15.32	19.15	18.05
Short-Term Debt	100.31	33.67	6.01	11.01	30.03	-
Current Portion of Long-Term Debt	0.05	0.09	-	-	-	-
Current Portion of Leases	-	-	0.64	1.09	1.35	0.84
Current Income Taxes Payable	4.72	11.12	5.18	5.86	16.02	5.22
Current Unearned Revenue	5.29	3.82	0.76	2.08	0.43	0.23
Other Current Liabilities	6.63	9.22	5.17	6.2	6.12	4.18
Total Current Liabilities	213.46	162.63	101.79	112.42	180.44	59.95
Long-Term Debt	106.35	49.53	12.63	-	-	-
Long-Term Leases	-	-	0.02	0.66	1.66	1.58
Long-Term Unearned Revenue	4.24	3.99	2.73	4.2	3.66	4.92
Long-Term Deferred Tax Liabilities	0.02	0.02	0.11	0.31	0.54	0.22
Total Liabilities	324.06	216.16	117.27	117.6	186.31	66.68
Common Stock	168.31	168.31	168.31	168.31	120	120
Additional Paid-In Capital	812.01	812.01	811.83	811.83	858.02	844.82
Retained Earnings	654	697.57	587.5	496.95	441.64	416.9
Treasury Stock	-45.17	-43.09	-10.82	-	-	-
Comprehensive Income & Other	-0.7	-0.73	-0.74	-0.74	-0.73	-0.69
Total Common Equity	1,588	1,634	1,556	1,476	1,419	1,381
Minority Interest	7.89	9.44	13.46	17.54	6.1	0.79
Shareholders' Equity	1,596	1,644	1,570	1,494	1,425	1,382
Total Liabilities & Equity	1,920	1,860	1,687	1,611	1,611	1,448
Total Debt	206.71	83.28	19.29	12.76	33.05	2.42
Net Cash (Debt)	180.14	194.95	133.89	226.95	494.08	673.55
Net Cash Growth	16.09%	45.61%	-41.01%	-54.07%	-26.65%	-21.76%
Net Cash Per Share	1.08	1.17	0.80	1.34	2.92	4.00
Filing Date Shares Outstanding	167.57	164.54	167.75	168.31	168	168
Total Common Shares Outstanding	167.57	164.54	167.75	168.31	168	168
Working Capital	588.94	559.08	554.88	596.35	726.92	934.9
Book Value Per Share	9.48	9.93	9.28	8.77	8.45	8.22
Tangible Book Value	1,546	1,591	1,513	1,435	1,383	1,368
Tangible Book Value Per Share	9.22	9.67	9.02	8.53	8.23	8.14
Buildings	-	-	241.94	241.02	191	94.66
Machinery	-	-	636	594.21	529.66	312.24
Construction In Progress	-	-	265.55	133.05	49.59	104.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.